⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL9303198 | 0.96 | — | — | |
| SCHEMBL6849940 | 0.93 | — | — | |
| SCHEMBL5664409 | 0.77 | HTR1A (0.37) | — | |
| SCHEMBL181056 | 0.77 | HTR1A (0.37) | — | |
| SCHEMBL4620757 | 0.77 | — | — | |
| SCHEMBL22635959 | 0.77 | — | — | |
| SCHEMBL45106 | 0.77 | — | — | |
| SCHEMBL2810989 | 0.76 | — | — | |
| SCHEMBL29406614 | 0.76 | — | — | |
| SCHEMBL28846445 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 288 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3664837-A1 | MULTI-FUNCTIONALIZED nOMV CONJUGATES | GlaxoSmithKline Biologicals S.A. (BE) | 2020-06-17 | — | — | EP | claimed |
| EP-3562510-A1 | BRANCHED PEG MOLECULES AND RELATED COMPOSITIONS AND METHODS | Genevant Sciences GmbH (CH) | 2019-11-06 | — | — | EP | claimed |
| WO-2019030271-A1 | MULTI-FUNCTIONALIZED nOMV CONJUGATES | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2019-02-14 | — | — | WO | claimed |
| WO-2018126084-A1 | BRANCHED PEG MOLECULES AND RELATED COMPOSITIONS AND METHODS | PHASERX, INC. (US) | 2018-07-05 | — | — | WO | claimed |
| EP-2488208-A1 | COMPOUNDS HAVING PEPTIDES CONJUGATED TO BONE TARGETING MOIETIES AND METHODS OF MAKING AND USING THEREOF | The Governors of the University of Alberta (CA) | 2012-08-22 | — | — | EP | claimed |
| WO-2011045668-A1 | COMPOUNDS HAVING PEPTIDES CONJUGATED TO BONE TARGETING MOIETIES AND METHODS OF MAKING AND USING THEREOF | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2011-04-21 | — | — | WO | claimed |
| EP-1704167-A1 | A METHOD TO MAKE A PEPTIDE-CARRIER CONJUGATE WITH A HIGH IMMUNOGENICITY | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) | 2006-09-27 | — | — | EP | claimed |
| WO-2005086775-A2 | LUMEN-EXPOSED MOLECULES AND METHODS FOR TARGETED DELIVERY | UTAH VENTURES II, L.P. (US) | 2005-09-22 | — | — | WO | claimed |
| WO-2005058968-A1 | A METHOD TO MAKE A PEPTIDE-CARRIER CONJUGATE WITH A HIGH IMMUNOGENICITY | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IT) | 2005-06-30 | — | — | WO | claimed |
| WO-2001040306-A9 | HUMAN ANTIBODIES AS DETECTION REAGENTS | BIOSITE DIAGNOSTICS INC (US) | 2002-05-30 | — | — | WO | claimed |
| WO-2024148281-A1 | CAMOUFLAGING ON CHIP, METHODS, AND SYSTEMS AND ITS USE FOR TESTING BIOLOGICAL AND NON-BIOLOGICAL ANALYTES | UNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTER (US) | 2024-07-11 | — | — | WO | disclosed |
| EP-4396373-A1 | SPATIAL MULTIOMICS USING IN SITU REVERSE TRANSCRIPTION | Becton, Dickinson and Company (US) | 2024-07-10 | — | — | EP | disclosed |
| EP-4396368-A1 | USE OF DECOY POLYNUCLEOTIDES IN SINGLE CELL MULTIOMICS | Becton, Dickinson and Company (US) | 2024-07-10 | — | — | EP | disclosed |
| WO-2024112615-A1 | COMPOSITIONS AND METHODS FOR DETECTION OF PROTEIN ANALYTES | RANGE BIOTECHNOLOGIES, INC. (US) | 2024-05-30 | — | — | WO | disclosed |
| WO-2024103161-A1 | DRUG CONJUGATE COMPOUNDS FOR STIMULATING THE ANTITUMOR IMMUNE RESPONSE | THERATECHNOLOGIES INC. (CA) | 2024-05-23 | — | — | WO | disclosed |
| WO-1995011694-A1 | COMPOSITIONS THAT SPECIFICALLY BIND TO COLORECTAL CANCER CELLS AND METHODS OF USING THE SAME | THOMAS JEFFERSON UNIVERSITY (US) | 1995-05-04 | — | — | WO | disclosed |
| EP-0569496-B1 | METHOD OF MEASURING LUMINESCENCE IN AN ASSAY BY LUMINESCENCE | CIS BIO INT (FR) | 1994-09-21 | — | — | EP | disclosed |
| WO-1994014437-A1 | PREVENTION AND TREATMENT OF SEPSIS | OPHIDIAN PHARMACEUTICALS, INC. (US) | 1994-07-07 | — | — | WO | disclosed |
| EP-0569496-A1 | METHOD OF MEASURING LUMINESCENCE IN AN ASSAY BY LUMINESCENCE. | CIS BIO INT (FR) | 1993-11-18 | — | — | EP | disclosed |
| WO-1992013264-A1 | METHOD OF MEASURING LUMINESCENCE IN AN ASSAY BY LUMINESCENCE | CIS BIO INTERNATIONAL (FR) | 1992-08-06 | — | — | WO | disclosed |